Director Corey Goodman buys 3,184,713 shares of ALXO for $5.0M at $1.57 amid unprofitable biotech operations.
Director Corey Goodman purchased 3,184,713 shares at $1.57 on 2026-02-02, increasing his holdings from 5,268,325 to 8,453,038 shares (+60.5%). The transaction value of $4,999,999.41 represents a substantial personal commitment in an unprofitable biotech company operating at a $-22.1M net loss with only $527.0K in latest quarterly revenue. The stock has appreciated 79.5% over the past 30 days and currently trades at $2.01, up 28% from the $1.57 purchase price, suggesting the market has responded positively post-transaction. This large director accumulation in a cash-burn-stage company with minimal revenue warrants scrutiny regarding the risk profile and capital allocation strategy.